智飞生物(300122.SZ)：重组带状疱疹ZFA01佐剂疫苗(CHO细胞)获得临床试验批准通知书
ZHIFEI-BIOL(SZ:300122) Ge Long Hui A P P·2026-02-09 08:14Group 1 - The core point of the article is that Zhifei Biological Products Co., Ltd. has received approval from the National Medical Products Administration for clinical trials of its recombinant varicella-zoster virus vaccine (ZFA01) in individuals aged 40 and above [1] Group 2 - The clinical trial will focus on the prevention of shingles, indicating a strategic move into the vaccine market for older populations [1]